Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Fuzheng Huayu Tablets for Treating Pulmonary Inflammation in Patients With COVID-19: A Case-Control Study

NCT04645407 is registered in ClinicalTrials.gov with ShuGuang Hospital as lead sponsor.

NCT NCT04645407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04645407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Fuzheng Huayu Tablets for Treating Pulmonary Inflammation in Patients With COVID-19: A Case-Control Study
Lead sponsor
ShuGuang Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2020
Completion date
April 15, 2020
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

novel coronavirus pneumonia